Simon X. Benito - 19 Jan 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ Simon X. Benito
Issuer symbol
INO
Transactions as of
19 Jan 2022
Net transactions value
-$4,140
Form type
4
Filing time
21 Jan 2022, 15:03:02 UTC
Previous filing
09 Dec 2021
Next filing
17 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise $4,400 +2,000 +3.5% $2.20 59,305 19 Jan 2022 Direct
transaction INO Common Stock Sale $8,540 -2,000 -3.4% $4.27* 57,305 19 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Common Stock Options Options Exercise $0 -2,000 -20% $0.000000 8,000 19 Jan 2022 Common Stock 2,000 $2.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.